Comparison BridgeBio Pharma (BBIO) with Competitors
BridgeBio Pharma (BBIO) industry is Biotechnology.
Profit Margin
BBIO-85.63%
Industry-0.77%
Upside-84.86%
Operating Margin
BBIO-54.47%
Industry-2055.25%
Upside+2000.78%
Debt-to-Equity
BBIO-116.44%
Industry28.27%
Upside-144.71%
Free Cash Flow Yield
BBIO-2.75%
Industry-1.75%
Upside-1.01%
P/E
BBIO-21.92
Industry-20.52
Upside-139.88%
P/S
BBIO27.92
Industry10.01
Upside+178.82%
P/B
BBIO123.68
Industry5.15
Upside+2303.06%